Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind dose-finding study of AZD1386 in knee osteoarthritis
jRCT2080220732Phase 2
- Sponsor
- AstraZeneca
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of AZD-1386 in knee osteoarthritis (OA) (4 arms), sponsored by AstraZeneca.
02
Drugs
AZD-1386
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2080220732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220732.